New York State Common Retirement Fund
STRO icon

New York State Common Retirement Fund’s Sutro Biopharma STRO Stock Holding History

New York State Common Retirement Fund’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,363
Closed -$8.86K – 3333
2025
Q1 		$8.86K Hold
1,363
– – ﹤0.01% 3089
2024
Q4 		$25.1K Hold
1,363
– – ﹤0.01% 3003
2024
Q3 		$47.1K Hold
1,363
– – ﹤0.01% 2882
2024
Q2 		$39.9K Buy
1,363
+21
+2% +$830 ﹤0.01% 3136
2024
Q1 		$75.8K Sell
1,342
-22
-2% -$972 ﹤0.01% 2843
2023
Q4 		$58.5K Sell
1,364
-12
-0.9% -$381 ﹤0.01% 2948
2023
Q3 		$47.7K Buy
1,376
+26
+2% +$1.13K ﹤0.01% 3035
2023
Q2 		$62.8K Sell
1,350
-7
-0.5% -$348 ﹤0.01% 3085
2023
Q1 		$62.7K Sell
1,357
-1,782
-57% -$113K ﹤0.01% 2934
2022
Q4 		$254K Buy
3,139
+1,227
+64% +$85.3K ﹤0.01% 2626
2022
Q3 		$106K Buy
1,912
+10
+0.5% +$592 ﹤0.01% 2997
2022
Q2 		$99K Sell
1,902
-1,226
-39% -$68.5K ﹤0.01% 3063
2022
Q1 		$257K Hold
3,128
– – ﹤0.01% 2722
2021
Q4 		$465K Sell
3,128
-7
-0.2% -$1.25K ﹤0.01% 2471
2021
Q3 		$592K Sell
3,135
-612
-16% -$116K ﹤0.01% 2368
2021
Q2 		$697K Buy
3,747
+1,397
+59% +$273K ﹤0.01% 2400
2021
Q1 		$535K Hold
2,350
– – ﹤0.01% 2416
2020
Q4 		$510K Buy
2,350
+1,250
+114% +$207K ﹤0.01% 2349
2020
Q3 		$111K Hold
1,100
– – ﹤0.01% 2881
2020
Q2 		$85K Hold
1,100
– – ﹤0.01% 3047
2020
Q1 		$112K Hold
1,100
– – ﹤0.01% 2720
2019
Q4 		$121K Hold
1,100
– – ﹤0.01% 2949
2019
Q3 		$100K Hold
1,100
– – ﹤0.01% 3029
2019
Q2 		$125K Buy
1,100
+990
+900% +$109K ﹤0.01% 3028
2019
Q1 		$13K Buy
+110
New +$11.4K ﹤0.01% 3144

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

New York State Common Retirement Fund's STRO Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Sutro Biopharma (STRO) in Q2 2025, closing a stake of 1,363 shares — an estimated $8.86K sold.

New York State Common Retirement Fund first reported a position in STRO in Q1 2019 and held it in 25 quarters. The position peaked at $697K in Q2 2021. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Sutro Biopharma position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 1,363 Sutro Biopharma shares in Q2 2025, an estimated $8.86K.
  • New York State Common Retirement Fund first reported a position in Sutro Biopharma in Q1 2019 and held it in 25 quarters.
  • New York State Common Retirement Fund's Sutro Biopharma position peaked at $697K in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.